Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (13), 1835-1837
- https://doi.org/10.1097/00002030-200209060-00021
Abstract
We studied the ability of providers to predict and estimate patient adherence to newly initiated highly active antiretroviral therapy (HAART). Nineteen providers referring 40 patients into an adherence study were surveyed. Widespread inaccuracy was found in providers' adherence predictions and estimates. Therefore, HAART should not be withheld solely on provider predictions of adherence. Providers should not rely on their own assessments when attempting to determine if patients are adhering to therapy.Keywords
This publication has 10 references indexed in Scilit:
- Effect of adherence to newly initiated antiretroviral therapy on plasma viral loadAIDS, 2001
- Factors Influencing Physicians’ Judgments of Adherence and Treatment Decisions for Patients with HIV DiseaseMedical Decision Making, 2001
- Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?AIDS, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Impact of Medical and Nonmedical Factors on Physician Decision Making for HIV/AIDS Antiretroviral TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Antiretroviral Therapy in AdultsJAMA, 2000
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Adherence in AIDS clinical trials: A framework for clinical research and clinical careJournal of Clinical Epidemiology, 1997